{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:28:51Z","timestamp":1781753331927,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"This work was supported by clinical research grant from Pusan National University Hospital 2016"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12891-017-1514-4","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T00:51:28Z","timestamp":1491871888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis"],"prefix":"10.1186","volume":"18","author":[{"given":"Ji-Heh","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Kyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wan","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Geun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"issue":"3","key":"1514_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1756-185X.2012.01729.x","volume":"15","author":"SG Lee","year":"2012","unstructured":"Lee SG, Park YE, Park SH, Kim TK, Choi HJ, Lee SJ, Kim SI, Lee SH, Kim GT, Lee JW, et al. Increased frequency of osteoporosis and BMD below the expected range for age among South Korean women with rheumatoid arthritis. Int J Rheum Dis. 2012;15(3):289\u201396.","journal-title":"Int J Rheum Dis"},{"key":"1514_CR2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12891-016-0952-8","volume":"17","author":"JH Lee","year":"2016","unstructured":"Lee JH, Sung YK, Choi CB, Cho SK, Bang SY, Choe JY, Hong SJ, Jun JB, Kim TH, Lee J, et al. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskeletal Disord. 2016;17:98.","journal-title":"BMC Musculoskeletal Disord"},{"issue":"4","key":"1514_CR3","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/ar3107","volume":"12","author":"SY Kim","year":"2010","unstructured":"Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K, Solomon DH. Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12(4):R154.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1514_CR4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00198-008-0743-7","volume":"20","author":"A Papaioannou","year":"2009","unstructured":"Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, et al. The impact of incident fractures on health-related quality of life: 5\u00a0years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2009;20(5):703\u201314.","journal-title":"Osteoporos Int"},{"issue":"12","key":"1514_CR5","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.10613","volume":"46","author":"DH Solomon","year":"2002","unstructured":"Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum. 2002;46(12):3136\u201342.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1514_CR6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3904\/kjim.2014.29.4.509","volume":"29","author":"JH Lee","year":"2014","unstructured":"Lee JH, Cho SK, Han M, Kim D, Bae SC, Sung YK. Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis? Korean J Intern Med. 2014;29(4):509\u201315.","journal-title":"Korean J Intern Med"},{"issue":"4\u20135","key":"1514_CR7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.berh.2015.09.005","volume":"29","author":"MB Mullen","year":"2015","unstructured":"Mullen MB, Saag KG. Evaluating and mitigating fracture risk in established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2015;29(4\u20135):614\u201327.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"1514_CR8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncprheum0773","volume":"4","author":"PP Geusens","year":"2008","unstructured":"Geusens PP, Roux CH, Reid DM, Lems WF, Adami S, Adachi JD, Sambrook PN, Saag KG, Lane NE, Hochberg MC. Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nat Clin Pract Rheumatol. 2008;4(5):240\u20138.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"12","key":"1514_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/679667f2-b4aa-42e8-8c59-511f60256420","volume":"8","author":"Z Feng","year":"2013","unstructured":"Feng Z, Zeng S, Wang Y, Zheng Z, Chen Z. Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. PLoS One. 2013;8(12), e80890.","journal-title":"PLoS One"},{"issue":"10","key":"1514_CR10","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00198-015-3253-4","volume":"26","author":"L Karlsson","year":"2015","unstructured":"Karlsson L, Lundkvist J, Psachoulia E, Intorcia M, Strom O. Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis. Osteoporos Int. 2015;26(10):2401\u201311.","journal-title":"Osteoporos Int"},{"issue":"8","key":"1514_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","volume":"18","author":"JA Cramer","year":"2007","unstructured":"Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int. 2007;18(8):1023\u201331.","journal-title":"Osteoporos Int"},{"key":"1514_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12891-016-1041-8","volume":"17","author":"B Cortet","year":"2016","unstructured":"Cortet B, Modi A, Tang J, Fan CP, Sajjan S, Weaver JP. Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis. BMC Musculoskeletal Disord. 2016;17:195.","journal-title":"BMC Musculoskeletal Disord"},{"issue":"4","key":"1514_CR13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jval.2010.11.010","volume":"14","author":"S Ross","year":"2011","unstructured":"Ross S, Samuels E, Gairy K, Iqbal S, Badamgarav E, Siris E. A meta-analysis of osteoporotic fracture risk with medication nonadherence. Value Health. 2011;14(4):571\u201381.","journal-title":"Value Health"},{"issue":"2","key":"1514_CR14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healthpol.2010.01.014","volume":"96","author":"M Hiligsmann","year":"2010","unstructured":"Hiligsmann M, Rabenda V, Bruyere O, Reginster JY. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Health Policy. 2010;96(2):170\u20137.","journal-title":"Health Policy"},{"issue":"1","key":"1514_CR15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44\u20137.","journal-title":"Value Health"},{"issue":"3","key":"1514_CR16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1514_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00198-011-1535-z","volume":"23","author":"P Hadji","year":"2012","unstructured":"Hadji P, Claus V, Ziller V, Intorcia M, Kostev K, Steinle T. GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates. Osteoporos Int. 2012;23(1):223\u201331.","journal-title":"Osteoporos Int"},{"issue":"12","key":"1514_CR18","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/acr.21777","volume":"64","author":"JS Richards","year":"2012","unstructured":"Richards JS, Cannon GW, Hayden CL, Amdur RL, Lazaro D, Mikuls TR, Reimold AM, Caplan L, Johnson DS, Schwab P, et al. Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis. Arthritis Care Res. 2012;64(12):1864\u201370.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"1514_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1756-185X.2012.01719.x","volume":"15","author":"SF Yu","year":"2012","unstructured":"Yu SF, Chou CL, Lai HM, Chen YC, Chiu CK, Kuo MC, Su YJ, Chen CJ, Cheng TT. Adherence to anti-osteoporotic regimens in a Southern Taiwanese population treated according to guidelines: a hospital-based study. Int J Rheum Dis. 2012;15(3):297\u2013305.","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"1514_CR20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00198-011-1635-9","volume":"23","author":"MH Cheen","year":"2012","unstructured":"Cheen MH, Kong MC, Zhang RF, Tee FM, Chandran M. Adherence to osteoporosis medications amongst Singaporean patients. Osteoporos Int. 2012;23(3):1053\u201360.","journal-title":"Osteoporos Int"},{"issue":"2","key":"1514_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-012-1984-z","volume":"24","author":"YK Soong","year":"2013","unstructured":"Soong YK, Tsai KS, Huang HY, Yang RS, Chen JF, Wu PC, Huang KE. Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan. Osteoporos Int. 2013;24(2):511\u201321.","journal-title":"Osteoporos Int"},{"key":"1514_CR22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1471-2474-14-276","volume":"14","author":"CK Chiu","year":"2013","unstructured":"Chiu CK, Kuo MC, Yu SF, Su BY, Cheng TT. Adherence to osteoporosis regimens among men and analysis of risk factors of poor compliance: a 2-year analytical review. BMC Musculoskeletal Disord. 2013;14:276.","journal-title":"BMC Musculoskeletal Disord"},{"issue":"7","key":"1514_CR23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.clinthera.2013.05.019","volume":"35","author":"TT Cheng","year":"2013","unstructured":"Cheng TT, Yu SF, Hsu CY, Chen SH, Su BY, Yang TS. Differences in adherence to osteoporosis regimens: a 2-year analysis of a population treated under specific guidelines. Clin Ther. 2013;35(7):1005\u201315.","journal-title":"Clin Ther"},{"issue":"2","key":"1514_CR24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00198-011-1549-6","volume":"23","author":"E Landfeldt","year":"2012","unstructured":"Landfeldt E, Strom O, Robbins S, Borgstrom F. Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA). Osteoporos Int. 2012;23(2):433\u201343.","journal-title":"Osteoporos Int"},{"issue":"2","key":"1514_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jbo.2016.02.006","volume":"5","author":"L Jacob","year":"2016","unstructured":"Jacob L, Hadji P, Kostev K. Age-related differences in persistence with bisphosphonates in women with metastatic breast cancer. J Bone Oncol. 2016;5(2):63\u20136.","journal-title":"J Bone Oncol"},{"issue":"12","key":"1514_CR26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/ard.61.12.1055","volume":"61","author":"E Lindqvist","year":"2002","unstructured":"Lindqvist E, Saxne T, Geborek P, Eberhardt K. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis. 2002;61(12):1055\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1514_CR27","first-page":"481","volume":"34","author":"K Eberhardt","year":"2007","unstructured":"Eberhardt K, Larsson BM, Nived K, Lindqvist E. Work disability in rheumatoid arthritis--development over 15\u00a0years and evaluation of predictive factors over time. J Rheumatol. 2007;34(3):481\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"1514_CR28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1514_CR29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00198-009-0930-1","volume":"21","author":"FE Cotte","year":"2010","unstructured":"Cotte FE, Fardellone P, Mercier F, Gaudin AF, Roux C. Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int. 2010;21(1):145\u201355.","journal-title":"Osteoporos Int"},{"issue":"7","key":"1514_CR30","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00198-012-2221-5","volume":"24","author":"C Hansen","year":"2013","unstructured":"Hansen C, Pedersen BD, Konradsen H, Abrahamsen B. Anti-osteoporotic therapy in Denmark--predictors and demographics of poor refill compliance and poor persistence. Osteoporos Int. 2013;24(7):2079\u201397.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1514_CR31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14656566.2015.997709","volume":"16","author":"JN Hoes","year":"2015","unstructured":"Hoes JN, Bultink IE, Lems WF. Management of osteoporosis in rheumatoid arthritis patients. Expert Opin Pharmacother. 2015;16(4):559\u201371.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"1514_CR32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1742-1241.2006.01059.x","volume":"60","author":"A Cooper","year":"2006","unstructured":"Cooper A, Drake J, Brankin E. Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study. Int J Clin Pract. 2006;60(8):896\u2013905.","journal-title":"Int J Clin Pract"},{"issue":"10","key":"1514_CR33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00198-007-0406-0","volume":"18","author":"H Ideguchi","year":"2007","unstructured":"Ideguchi H, Ohno S, Hattori H, Ishigatsubo Y. Persistence with bisphosphonate therapy including treatment courses with multiple sequential bisphosphonates in the real world. Osteoporos Int. 2007;18(10):1421\u20137.","journal-title":"Osteoporos Int"},{"issue":"1","key":"1514_CR34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00198-010-1274-6","volume":"22","author":"SL Silverman","year":"2011","unstructured":"Silverman SL, Schousboe JT, Gold DT. Oral bisphosphonate compliance and persistence: a matter of choice? Osteoporos Int. 2011;22(1):21\u20136.","journal-title":"Osteoporos Int"},{"key":"1514_CR35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11657-015-0231-6","volume":"10","author":"H Kishimoto","year":"2015","unstructured":"Kishimoto H, Maehara M. Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA. Arch Osteoporos. 2015;10:231.","journal-title":"Arch Osteoporos"},{"issue":"8","key":"1514_CR36","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.clinthera.2015.05.505","volume":"37","author":"K Iglay","year":"2015","unstructured":"Iglay K, Cao X, Mavros P, Joshi K, Yu S, Tunceli K. Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy. Clin Ther. 2015;37(8):1813\u201321. e1811.","journal-title":"Clin Ther"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-017-1514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:37:10Z","timestamp":1498387030000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-017-1514-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1186\/s12891-017-1514-4","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,11]]},"article-number":"152"}}